BRIEF-Aerpio Pharmaceuticals Inc Entered Into An Asset Purchase Agreement With Eyepoint Pharmaceuticals Inc
BRIEF-Aerpio Pharmaceuticals Inc Entered Into An Asset Purchase Agreement With Eyepoint Pharmaceuticals Inc
簡介-Aerpio製藥公司與Eyepoint製藥公司達成資產購買協議
Aug 23 (Reuters) - Aerpio Pharmaceuticals Inc :
* AERPIO PHARMACEUTICALS INC - ON AUGUST 17, ENTERED INTO AN ASSET PURCHASE AGREEMENT WITH EYEPOINT PHARMACEUTICALS, INC.
* AERPIO PHARMACEUTICALS - PURSUANT TO AGREEMENT, AGREED TO SELL ALL OF CO'S RIGHT, TITLE, INTEREST IN AND TO CERTAIN PATENTS AND PATENT APPLICATIONS
Source text for Eikon: [ Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透8月23日電-Aerpio製藥公司：
*AERPIO製藥公司-8月17日，與EYEPOINT製藥公司簽訂了一項資產購買協議。
*AERPIO製藥公司-根據協議，同意出售CO在某些專利和專利申請中的所有權利、所有權、權益和對這些專利和專利申請的所有權利、所有權、權益
Eikon的源文本：[進一步的公司報道：
(Reurs.Briefs@thomsonreurs.com；)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。